Rochester Clinical Research Wins “Best Clinical Trial Site Company” At The 2023 World Vaccine Congress Awards!
Rochester Clinical Research is thrilled to announce that we have been awarded the Vaccine Industry Excellence (VIE) award for “Best […]
General
RCR Helps Acute Migraine Nasal Spray Get FDA Approved
Rochester Clinical Research takes great pride in its contribution to Pfizer’s groundbreaking study on Zavzpret (zavegepant) migraine nasal spray, which
RCR’s, Dr. Matthew Davis, on Channel 10 News talking about our pediatric Lyme Disease study
Doctors working to develop a vaccine for Lyme Disease Patrick Moussignac News10NBCApril 26, 2023 – 5:56 PM ROCHESTER, N.Y. –
General
BPOC Launches Atlas Clinical Research, a Premier Clinical Research Site Platform
Simultaneously forms strategic partnership with Rochester Clinical Research, marking the foundational clinical research site of the new platform CHICAGO, April 12,
SCRS Diversity & Oncology Summit 2023
Rochester Clinical Research recently had the privilege to attend the SCRS Diversity Summit in Austin, TX. We attended numerous informative
Why an at-home test for multiple viruses can wait!
Swabbing ourselves has become common. At home, Covid-19 tests were made so convenient that people could stay home and find
Know What You’re Up Against With RSV
Hospitals around the country are seeing a rise in RSV (respiratory syncytial virus) cases this season, especially among pediatric patients.
Why It Is Important To Get Your Flu Shot This Year!
The flu virtually disappeared for two years as the pandemic raged. But influenza appears poised to stage a comeback this
Seasonal Killers Have a New Foe
Better Protection against Flu and RSV – mRNA Technology is a Game Changer in vaccine trials at Rochester Clinical Research
RCR Helps with Acute Migraine Treatment Advancements!
Rochester Clinical Research is proud to have worked on the BioHaven studies that show promise in treating acute migraines with